ResMed
Clinical trials sponsored by ResMed, explained in plain language.
ResMed
RMD
NYSE
A medical device company specializing in sleep apnea and respiratory care products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a Finger-Worn gadget diagnose sleep apnea? Results expected Oct 2026 (estimated)
- Wearable watch could replace saliva tests for sleep disorders Results expected Oct 2026 (estimated)
- Could a mouthpiece replace the CPAP machine for sleep apnea? Results expected Oct 2026 (estimated)
- New software aims to take the guesswork out of CPAP settings Results expected Dec 2026 (estimated)
- Could a breathing machine help you sleep better? new trial investigates Results expected Dec 2026 (estimated)